06/03/2026
Let's talk fatty liver disease....
The liver data is unlike anything we've seen from a weight loss drug AKA ratatouille: The Glucagon Aspect
- 86% liver fat reduction at 48 weeks, most of it within the first 24 weeks
- 93% of patients achieved completely normal liver fat levels
For context, Tirzepatide onlyreduces liver fat by 45–57%.
One in three adults has fatty liver disease and most don't know it.
The reason for this is retatrutide's glucagon receptor. It tells the liver directly to burn its stored fat, not just reduce calories coming in..
